Skip to main content
Log in

Occult metastases from T1–T2 supraglottic carcinoma: role of primary tumor localization

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The present study was undertaken to evaluate the role of localization on the rate of occult metastasis in early stage supraglottic laryngeal carcinoma. We selected carefully 32 T1–2 clinically N0 patients without epilarynx involvement and 39 T1–2 clinically N0 patients with epilarynx involvement from among patients with supraglottic laryngeal carcinoma. All patients underwent simultaneous unilateral or bilateral neck dissection with laryngeal surgery. The rate of the occult metastases was 3.1% in patients without epilarynx involvement, whereas it was 20.5% in patients with epilarynx involvement. Within the supraglottic larynx, two subregions can be distinguished: the epilarynx and the lower supraglottis. Our results suggest the possibility of omitting elective neck treatment in T1–2N0 supraglottic laryngeal carcinoma without epilarynx involvement. Observation under strict follow-up may be an option to routine neck treatment in T1–2N0 supraglottic laryngeal carcinoma without epilarynx involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maurizi M, Paludetti G, Galli J, Ottaviani F, D’Abramo G, Almadori G (1999) Oncological and functional outcome of conservative surgery for primary supraglottic cancer. Eur Arch Otorhinolaryngol 256:283–290

    Article  CAS  PubMed  Google Scholar 

  2. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W (1998) Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 124:1245–1250

    Article  CAS  PubMed  Google Scholar 

  3. Rodrigo JP, Suarez C, Silver CE, Rinaldo A, Ambrosch P, Fagan JJ, Genden EM, Ferlito A (2008) Transoral laser surgery for supraglottic cancer. Head Neck 30:658–666

    Article  PubMed  Google Scholar 

  4. Petrovic Z, Krejovic B, Janosevic S (1997) Occult metastases from supraglottic laryngeal carcinoma. Clin Otolaryngol Allied Sci 22:522–524

    Article  CAS  PubMed  Google Scholar 

  5. Guney E, Yigitbasi OG (1999) Management of N0 neck in T1–T2 unilateral supraglottic cancer. Ann Otol Rhinol Laryngol 108:998–1003

    Article  CAS  PubMed  Google Scholar 

  6. Welsh LW, Welsh JJ, Rizzo TA Jr (1983) Laryngeal spaces and lymphatics: current anatomic concepts. Ann Otol Rhinol Laryngol Suppl 105:19–31

    Article  CAS  PubMed  Google Scholar 

  7. Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York

    Book  Google Scholar 

  8. Koybasioğlu A, Uslu S, Yilmaz M, Inal E, Ileri F, Asal K (2002) Lymphatic metastasis to the supraretrospinal recess in laryngeal squamous cell carcinoma. Ann Otol Rhinol Laryngol 111(1):96–99

    Article  PubMed  Google Scholar 

  9. Cağli S, Yüce I, Güney E (2007) Is routine inclusion of level IV necessary in neck dissection for clinically N0 supraglottic carcinoma? Otolaryngol Head Neck Surg 136(2):287–290

    Article  PubMed  Google Scholar 

  10. Andersen PE, Cambronero E, Shaha AR, Shah JP (1996) The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 172:689–691

    Article  CAS  PubMed  Google Scholar 

  11. Snow GB (1993) The N0 neck in head and neck cancer patients. Eur Arch Otorhinolaryngol 250:423

    Article  Google Scholar 

  12. Gallo O, Boddi V, Bottai GV, Parrella F, Storchi OF (1996) Treatment of the clinically negative neck in laryngeal cancer patients. Head Neck 18:566–572

    Article  CAS  PubMed  Google Scholar 

  13. Sessions DG, Lenox J, Spector GJ (2005) Supraglottic laryngeal cancer. Analysis of treatment results. Laryngoscope 115:1402–1410

    Article  PubMed  Google Scholar 

  14. Goudakos JK, Markou K, Nikolaou A, Themelis C, Vital V (2008) Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: A systematic review. Eur J Surg Oncol. In press 1–7

  15. Lefebvre JL, Buisset E, Coche-Dequeant B, Van JT, Prevost B, Hecquet B, An Demaille (1995) Epilarynx: pharynx or Larynx? Head Neck 17:377–381

    Article  CAS  PubMed  Google Scholar 

  16. Scola B, Fernández-Vega M, Martínez T, Fernández-Vega S, Ramirez C (2001) Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 124:195–198

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

We do not have any financial relationship with the organization that sponsored the research. We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to İmdat Yüce.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yüce, İ., Çağlı, S., Bayram, A. et al. Occult metastases from T1–T2 supraglottic carcinoma: role of primary tumor localization. Eur Arch Otorhinolaryngol 266, 1301–1304 (2009). https://doi.org/10.1007/s00405-008-0859-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-008-0859-6

Keywords

Navigation